Artificial intelligence is quickly becoming a helpful tool within the digital pathology ecosystem. AI technology can now support pathologists during multiple digital workflow stages, from triage to assisting with menial…
Read More
Pathology is changing fast—and if you’ve ever felt like the transition from a physical microscope to a digital screen is a bit daunting, this episode is for you. Lumea CEO…
Rachel Olsen Market Intelligence & Content Manager Rachel Olsen is Market Intelligence & Content Manager at Lumea, where she leads editorial development, competitive intelligence, and content strategy for the U.S….
Planning your professional development calendar for 2026? The right digital pathology conferences can accelerate your transformation journey more than almost anything else, putting you in the same room as the…
Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing
Lumea Announces Collaboration with Cleveland Diagnostics to Enable Greater Access to IsoPSA® Testing for Prostate Cancer Risk Stratification LEHI, UT, UNITED STATES, December 17, 2025 /EINPresswire.com/ — Lumea, the U.S….
The digital pathology landscape is evolving at an electrifying pace. As the industry matures, the pathways to tangible value and strategic revenue generation are becoming clearer. A recent article analyzing…
How the BxChip™ Delivers 60% Higher Grading Accuracy In the world of prostate cancer, the Gleason score is the gold standard for treatment decisions. It’s the compass that guides urologists…
ZayaAI is embedding Lumea’s viewer into the Zaya LIS, creating a single digital workspace for pathologists. This streamlines workflows and boosts efficiency. LEHI, UT, UNITED STATES, December 9, 2025 /EINPresswire.com/…
In this episode of PathPulse, James is joined by Dr. Matthew Cecchini, a celebrated pathologist, educator, and a Top 100 Trailblazer recognized by The Pathologist magazine. Their conversation dives deep…
The Challenge: A Critical Bottleneck in Precision Diagnostics For modern healthcare to truly deliver on the promise of precision medicine, ancillary tests like genomic and molecular assays are essential. These…
